Ancilia Therapeutics is a startup based in the United States, 1 tracked investor.
Ancilia Therapeutics is a startup based in the United States. Brouky records 1 investor associated with the company.
Ancilia Therapeutics develops a computational therapeutic platform focused on microbiome-related diseases, applying computational methods to discover or design microbiome-targeted therapies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.